Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Marc Peeters
Profile
Projects
Publications
Activities
Awards & Distinctions
252
Results
2018
Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer
Pashalina Kehagias
Caroline Vandeputte
Lieveke Ameye
Hakim El Housni
Jean-Francois Laes
Amelie Deleporte
Karen Geboes
Thierry Delaunoit
Gauthier Demolin
Marc Peeters
et al.
C3
Conference
2018
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib
Pashalina Kehagias
Caroline Vandeputte
Lieveke Ameye
Hakim El Housni
Amelie Deleporte
Karen Geboes
Thierry Delaunoit
Marc Peeters
Gauthier Demolin
Lionel D'Hondt
et al.
C3
Conference
2018
2017
Baseline cell-free DNA (cfDNA) and metabolic tumor volume (MTV) independently predict outcome in metastatic chemorefractory colorectal cancer (mCRC)
Erwin Woff
Pashalina Kehagias
Caroline Vandeputte
Tarek Kamoun
Thomas Guiot
Lieveke Ameye
Karen Geboes
Thierry Delaunoit
Gauthier Demolin
Marc Peeters
et al.
C3
Conference
2017
Children's International Polyposis (CHIP) study : a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis
Carol A Burke
Robin Phillips
Manuela F Berger
Chunming Li
Margaret Noyes Essex
Dinu Iorga
Patrick M Lynch
the study site investigators
Catharina Dhooge
Marc Peeters
A2
Journal Article
in
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY
2017
2014
Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC) : REGARD-C study
Alain Hendliz
Amélie Deleporte
Thierry Delaunois
Marc Peeters
Gauthier Demolin
Jos Janssens
Stephane Holbrechts
Raphaël Maréchal
Javier Carasco
Marc Van Den Eynde
et al.
C3
Conference
2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer : the SIRFLOX study
Peter Gibbs
Val Gebski
Mark Van Buskirk
Kenneth Thurston
David N Cade
Guy A Van Hazel
the SIRFLOX Study group
Karen Geboes
Marc Peeters
A1
Journal Article
in
BMC CANCER
2014
2013
Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
Jeroen Mertens
Sylvie De Bruyne
Nancy Van Damme
Peter Smeets
Wim Ceelen
Roberto Troisi
Stéphanie Laurent
Karen Geboes
Marc Peeters
Ingeborg Goethals
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2013
2012
A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer
H Bleiberg
A Vandebroek
I Deleu
P Vergauwe
HR Kalantari
G D'Haens
M Paesmans
Marc Peeters
A Efira
Y Humblet
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2012
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer
Uday Bharat Patel
Gina Brown
Harm Rutten
Nicholas West
David Sebag-Montefiore
Robert Glynne-Jones
Eric Rullier
Marc Peeters
Eric Van Cutsem
Sergio Ricci
et al.
A1
Journal Article
in
ANNALS OF SURGICAL ONCOLOGY
2012
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study
Eric Van Cutsem
Sabine Tejpar
Dirk Vanbeckevoort
Marc Peeters
Yves Humblet
Hans Gelderblom
Jan B Vermorken
Frederic Viret
Bengt Glimelius
Elisa Gallerani
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2012
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
R Maréchal
B Vos
M Polus
T Delaunoit
Marc Peeters
P Demetter
A Hendlisz
A Demols
D Franchimont
G Verset
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2012
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model
Christel Vangestel
Christophe Van De Wiele
Gilles Mees
Koen Mertens
Steven Staelens
Chris Reutelingsperger
Patrick Pauwels
Nancy Van Damme
Marc Peeters
A1
Journal Article
in
MOLECULAR IMAGING
2012
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study
Daphne Hompes
André D'Hoore
Eric Van Cutsem
Steffen Fieuws
Wim Ceelen
Marc Peeters
Kurt Van der Speeten
Claude Bertrand
Hugues Legendre
Joseph Kerger
A1
Journal Article
in
ANNALS OF SURGICAL ONCOLOGY
2012
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
Sylvie De Bruyne
Nancy Van Damme
Peter Smeets
Liesbeth Ferdinande
Wim Ceelen
Jeroen Mertens
Christophe Van De Wiele
Roberto Troisi
Louis Libbrecht
Stéphanie Laurent
et al.
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2012
2011
'Doe-het-zelf chemotherapie advies' : gevaarlijke ontwikkelingen via het worldwide web
Karen Geboes
Sylvie Rottey
Stéphanie Laurent
Johan Vandenbroucke
Marc Peeters
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2011
99mTc-(CO)3 His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab
Christel Vangestel
Christophe Van De Wiele
Nancy Van Damme
Steven Staelens
Patrick Pauwels
Chris PM Reutelingsperger
Marc Peeters
A1
Journal Article
in
JOURNAL OF NUCLEAR MEDICINE
2011
An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC)
Nancy Van Damme
Sylvie De Bruyne
Jeroen Mertens
Christophe Van De Wiele
Wim Ceelen
Peter Smeets
Liesbeth Ferdinande
Stéphanie Laurent
Karen Geboes
Marc Peeters
C3
Conference
2011
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
Louke Delrue
Veerle Casneuf
Nancy Van Damme
Peter Blanckaert
Marc Peeters
Wim Ceelen
Philippe Duyck
A1
Journal Article
in
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE
2011
Assessment of tumor genotypes in metastatic colorectal cancer (MCRC): mutations beyond KRAS codons 12 and 13 as predictive biomarkers of response to panitumumab (PMAB) in a randomized, phase 3 study
Marc Peeters
Kelly S Oliner
Salvatore Siena
Eric Van Cutsem
Jing Huang
Yves Humblet
Jean-Luc Van Laethem
Thierry Andre
Jeffery Wiezorek
Scott D Patterson
C3
Conference
2011
Assurance de qualité pour le cancer rectal : phase 3 : méthodes statistique visant à comparer les centres sur base d'un ensemble d'indicateurs de qualité
Els Goetghebeur
Ronan Van Rossem
Katrien Baert
Kürt Vanhoutte
Tom Boterberg
Pieter Demetter
Mark De Ridder
David Harrington
Marc Peeters
Guy Storme
et al.
Report
2011
Cystic masses of the pancreas : how useful is cyst fluid analysis in the diagnosis?
Ercan Cesmeli
Stéphanie Laurent
Liesbeth Ferdinande
Barbara Claerhout
Marc Peeters
Martine De Vos
C3
Conference
2011
EGFR in melanoma : clinical significance and potential therapeutic target
Barbara Boone
Koen Jacobs
Liesbeth Ferdinande
Jasmien Taildeman
Jo Lambert
Marc Peeters
Marc Bracke
Patrick Pauwels
Lieve Brochez
A1
Journal Article
in
JOURNAL OF CUTANEOUS PATHOLOGY
2011
Efficacy of the combined use of bevacizumab and irinotecan in a human colorectal cancer xenograft model analysed by SPECT imaging
Christel Vangestel
Christophe Van De Wiele
Karen Geboes
Stéphanie Laurent
Nancy Van Damme
Marc Peeters
C3
Conference
2011
Evaluation of panitumumab (PMAB) plus folfiri versus folfiri alone as second-line therapy in patients (PTS) with metastatic colorectal cancer (MCRC) receiving prior bevacizumab (BEV) in study 20050181
Marc Peeters
Timothy Price
Andrew Strickland
Tudor-Eliade Ciuleanu
Werner Scheithauer
Seamus O'Reilly
Maccon Keane
David Spigel
Ying Tian
Kartik Krishnan
C3
Conference
2011
FDG uptake in primary squamous cell carcinoma of the head and neck : the relationship between overexpression of glucose transporters and hexokinases, tumour proliferation and apoptosis
Philippe Deron
Christel Vangestel
Ingeborg Goethals
ALEXANDRA DE POTTER
Marc Peeters
Hubert Vermeersch
Christophe Van De Wiele
A1
Journal Article
in
NUKLEARMEDIZIN-NUCLEAR MEDICINE
2011
FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC)
Nancy Van Damme
Sylvie De Bruyne
Jeroen Mertens
Christophe Van De Wiele
Wim Ceelen
Peter Smeets
Liesbeth Ferdinande
Stéphanie Laurent
Karen Geboes
Marc Peeters
C3
Conference
2011
Familial adenomatous polyposis: clinical presentation, detection and surveillance
Stéphanie Laurent
D Franchimont
JP Coppens
K Leunen
L Macken
Marc Peeters
O Plomteux
M Polus
Bruce Poppe
C Sempoux
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2011
In vivo imaging of apoptosis in oncology : an update
Christel Vangestel
Marc Peeters
Gilles Mees
Ruth Oltenfreiter
Hendrikus H Boersma
Philip H Elsinga
Chris Reutelingsperger
Nancy Van Damme
Bart De Spiegeleer
Christophe Van De Wiele
A1
Journal Article
in
MOLECULAR IMAGING
2011
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
Monirath Hav
Louis Libbrecht
Liesbeth Ferdinande
Piet Pattyn
Stéphanie Laurent
Marc Peeters
Marleen Praet
Patrick Pauwels
A1
Journal Article
in
VIRCHOWS ARCHIV
2011
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent
Veerle Casneuf
Louke Delrue
Nancy Van Damme
Pieter Demetter
Philippe Robert
Claire Corot
Philippe Duyck
Wim Ceelen
Tom Boterberg
Marc Peeters
A1
Journal Article
in
RADIATION RESEARCH
2011
PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC)
Nancy Van Damme
Sylvie De Bruyne
Liesbeth Ferdinande
Wim Ceelen
Jeroen Mertens
Christophe Van De Wiele
Stéphanie Laurent
Peter Smeets
Karen Geboes
Marc Peeters
C3
Conference
2011
Panitumumab (PMAB) in combination with chemotherapy (CT) versus CT alone: health-related quality of life (HRQOL) in patients (PTS) with wild-type (WT) KRAS metastatic colorectal cancer (MCRC)
Marc Peeters
Lee Bennett
Zhongyun Zhao
Beth Barber
Xiaolei Zhou
Jessica Zhang
Feng Xu
Jeffery Wiezorek
Jean-Yves Douillard
C3
Conference
2011
Preoperative chemotherapy for colorectal liver metastases : prediction of response by DCE-MRI abd FDG-PET/CT?
Sylvie De Bruyne
Peter Smeets
Nancy Van Damme
Wim Ceelen
Christophe Van De Wiele
Stéphanie Laurent
Karen Geboes
Jeroen Mertens
Marc Peeters
C3
Conference
2011
2010
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer
T Meyer
ME Caplin
DH Palmer
JW Valle
M Larvin
JS Waters
F Coxon
I Borbath
Marc Peeters
E Nagano
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
Jean-Luc Van Laethem
Pascal Hammel
Françoise Mornex
David Azria
Geertjan Van Tienhoven
Philippe Vergauwe
Marc Peeters
Marc Polus
Marleen Praet
Murielle Mauer
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2010
Deoxycitidine kinase is associated with prolonged survival after adjuvant gemcitabine for resected pancreatic adenocarcinoma
Raphael Marechal
John R Mackey
Raymond Lai
Pieter Demetter
Marc Peeters
Marc Polus
Carol E Cass
Isabelle Salmon
Jacques Deviere
Jean-Luc Van Laethem
A1
Journal Article
in
CANCER
2010
Diarrhea and the rationale to use Sandostatin®
Marc Peeters
J Van den Brande
S Francque
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2010
EORTC Elderly Task Force experts' opinion for the treatment of colon cancer in older patients
AG Pallis
D Papamichael
R Audisio
Marc Peeters
G Folprecht
D Lacombe
E Van Cutsem
A1
Journal Article
in
CANCER TREATMENT REVIEWS
2010
EUS predicts local resection for rectal cancer
Ercan Cesmeli
Karen Geboes
Pieter-Jan De Munck
Barbara Claerhout
Wim Ceelen
Piet Pattyn
Danny De Looze
Marc Peeters
Martine De Vos
C3
Conference
2010
EUS predicts local resection for rectal cancer
Ercan Cesmeli
Karen Geboes
Pieter-Jan De Munck
Barbara Claerhout
Wim Ceelen
Piet Pattyn
Danny De Looze
Marc Peeters
Martine De Vos
C3
Conference
2010
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas
Nancy Van Damme
Philippe Deron
Nadine Van Roy
Pieter Demetter
Alain Bols
Jo Van Dorpe
Filip Baert
Jean-Luc Van Laethem
Franki Speleman
Patrick Pauwels
et al.
A1
Journal Article
in
BMC CANCER
2010
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells
Christel Vangestel
Marc Peeters
Ruth Oltenfreiter
Yves D'Asseler
Steven Staelens
Magali Van Steenkiste
Jan Philippé
Dennis Kusters
Chris Reutelingsperger
Nancy Van Damme
et al.
A1
Journal Article
in
NUCLEAR MEDICINE AND BIOLOGY
2010
In vivo toxicity and bioavailability of taxol (R) and a paclitaxel/beta-cyclodextrin formulation in a rat model during HIPEC
Wim Bouquet-Geerardyn
Wim Ceelen
Els Adriaens
Ana Almeida
Thomas Quinten
Filip De Vos
Piet Pattyn
Marc Peeters
Jean Paul Remon
Chris Vervaet
A1
Journal Article
in
ANNALS OF SURGICAL ONCOLOGY
2010
KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis
V Deschoolmeester
C Boeckx
M Baay
J Weyler
W Wuyts
E Van Marck
Marc Peeters
F Lardon
JB Vermorken
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2010
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
Alain Hendlisz
Marc Van den Eynde
Marc Peeters
Geert Maleux
Bieke Lambert
Jaarke Vannoote
Katrien De Keukeleire
Chris Verslype
Luc Defreyne
Eric Van Cutsem
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2010
Psychometric evaluation of the FACT colorectal cancer symptom index (FCSI-9): reliability, validity, responsiveness, and clinical meaningfulness
Hilary H Colwell
Susan D Mathias
Michelle P Turner
John Lu
Nicola Wright
Marc Peeters
David Cella
Giovanna Devercelli
A1
Journal Article
in
ONCOLOGIST
2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer
Marc Peeters
Timothy Jay Price
Andrés Cervantes
Alberto F Sobrero
Michel Ducreux
Yevje, Hotko
Thierry André
Emily Chan
Florian Lordick
Cornelis JA Punt
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2010
Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation
Bea Pauwels
An Wouters
Marc Peeters
Jan B Vermorken
Filip Lardon
A1
Journal Article
in
FUTURE ONCOLOGY
2010
SPECT imaging of apoptotic tumor response in a colorectal tumor model
Christel Vangestel
Nancy Van Damme
Gilles Mees
Steven Staelens
Christophe Van De Wiele
Marc Peeters
C3
Conference
2010
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
Isabelle Debergh
Nancy Van Damme
Piet Pattyn
Marc Peeters
Wim Ceelen
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2010
Unravelling mechanisms of non-invasive imaging of pancreatic cancer
Veerle Casneuf
Marc Peeters
Christophe Van De Wiele
Nancy Van Damme
Dissertation
2010
2009
A phase 1 B/2 trial of AMG 655 and panitumumab (pmab) for the treatment (tx) of metastatic colorectal cancer (mCRC): safety results.
P Rougier
J Infante
JL Van Laethem
J Stephenson
H Uronis
L Schwartzberg
L Chen
B Yang
D Smethurst
Marc Peeters
C3
Conference
2009
Alles over de uitbreiding van de indicatie voor capecitabine (Xeloda)
Marc Peeters
A4
Journal Article
in
MEDI-SFEER
2009
Amphiregulin and Epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with Cetuximab
Bart Jacobs
Wendy De Roock
Hubert Piessevaux
Robin Van Oirbeek
Bart Biesmans
Jef De Schutter
Steffen Fieuws
Jo Vandesompele
Marc Peeters
Jean-Luc Van Laethem
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2009
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: An experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy
Veerle Casneuf
Pieter Demetter
Tom Boterberg
Louke Delrue
Marc Peeters
Nancy Van Damme
A1
Journal Article
in
ONCOLOGY REPORTS
2009
Association of Progression-free Survival, Overall Survival, and Patient-reported Outcomes by Skin Toxicity and KRAS Status in Patients Receiving Panitumumab Monotherapy
Marc Peeters
S Siena
E Van Cutsem
A Sobrero
A Hendlisz
S Cascinu
H Kalofonos
G Devercelli
M Wolf
RG Amado
A1
Journal Article
in
CANCER
2009
Bevacizumab and 5-FU + Oxaliplatin or irinotecan as neoadjuvant therapy for patients with non resectable liver metastases
BERT VAN DEN BOSSCHE
KIM BOTERBERGH
Stéphanie Laurent
ISABEL DERO
Frederik Berrevoet
Marc Peeters
Bernard de Hemptinne
Roberto Troisi
C3
Conference
2009
Carcinoid heart disease: a hidden complication of neuroendocrine tumours
ISABEL DERO
Michel De Pauw
I Borbath
T Delaunoit
P Demetter
G Demolin
A Hendlisz
Piet Pattyn
S Pauwels
G Roeyen
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer : a multicentre two-part phase I/II study
Jean-Luc Raoul
Jean-Luc Van Laethem
Marc Peeters
Catherine Brezault
Fares Husseini
Laurent Cals
Johannes Nippgen
Anja-Helena Loos
Philippe Rougier
A1
Journal Article
in
BMC CANCER
2009
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis
Gilles Mees
Philippe Fonteyne
Wim Ceelen
Tom Boterberg
Patrick Pauwels
Christel Vangestel
Nancy Van Damme
Marc Peeters
Rudi Dierckx
Christophe Van De Wiele
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2009
Comparison of two contrast agents for DCE-MRI evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
Peter Smeets
Nancy Van Damme
Wim Ceelen
CAROLINE VANDE WALLE
Christophe Van De Wiele
ISABEL DERO
Karen Geboes
Stéphanie Laurent
Marc Peeters
C3
Conference
2009
Defining the optimal therapy sequence in synchronous respectable liver metastases from colorectal cancers: a decision analysis approach
ELS VAN DESSEL
KJELL FIERENS
Piet Pattyn
Yves Van Nieuwenhove
Marc Peeters
Nancy Van Damme
Frederik Berrevoet
Wim Ceelen
C3
Conference
2009
Diagnostic pitfalls in digestive neuroendocrine tumours
I Borbath
F Jamar
T Delaunoit
P Demetter
G Demolin
A Hendlisz
Piet Pattyn
Marc Peeters
G Roeyen
E Van Cutsem
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
Diffusion magnetic resonance imaging as surrogate marker to anti-VEGF treatment response in MCTC
Peter Smeets
Nancy Van Damme
CAROLINE VANDE WALLE
Christophe Van De Wiele
ISABEL DERO
Karen Geboes
Stéphanie Laurent
Marc Peeters
C3
Conference
2009
Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicenter prospective phase II clinical study
D Hompes
A D'Hoore
E Van Cutsem
Wim Ceelen
Marc Peeters
K Van der Speeten
C Bertrand
J Kerger
H Legendre
C3
Conference
2009
Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma
Philippe Fonteyne
Veerle Casneuf
Patrick Pauwels
Nancy Van Damme
Marc Peeters
Rudi Dierckx
Christophe Van De Wiele
A1
Journal Article
in
HISTOLOGY AND HISTOPATHOLOGY
2009
FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases
Rudi Dierckx
Alex Maes
Marc Peeters
Christophe Van De Wiele
A1
Journal Article
in
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study
Stéphanie Laurent
Els Monsaert
Tom Boterberg
A Demols
I Borbath
M Polus
A Hendlisz
Bernard de Hemptinne
C Mahin
P Scalliet
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2009
Forcing cancer cells to commit suicide
Christel Vangestel
Christophe Van De Wiele
Gilles Mees
Marc Peeters
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2009
Haalbaarheid van een georganiseerde screening naar colorectaal carcinoom in de laag risicopopulatie
Bart Van Imschoot
Stéphanie Laurent
ISABEL DERO
Katleen De Helt
Nancy Van Damme
Marc Peeters
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2009
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
R Maréchal
JR Mackey
R Lai
P Demetter
Marc Peeters
M Polus
CE Cass
J Young
I Salmon
J Devière
et al.
A1
Journal Article
in
Clinical Cancer Research
2009
In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC
Wim Bouquet-Geerardyn
Tom Boterberg
Wim Ceelen
Piet Pattyn
Marc Peeters
Marc Bracke
Jean Paul Remon
Chris Vervaet
A1
Journal Article
in
INTERNATIONAL JOURNAL OF PHARMACEUTICS
2009
Locoregional and radioisotopic targeted treatment of neuroendocrine tumours
A Hendlisz
P Flamen
M Van den Eynde
I Borbath
P Demetter
G Demolin
Piet Pattyn
S Pauwels
Marc Peeters
G Roeyen
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo
Isabelle Debergh
Nancy Van Damme
Piet Pattyn
Marc Peeters
Wim Ceelen
C3
Conference
2009
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo
Isabelle Debergh
Nancy Van Damme
Piet Pattyn
Marc Peeters
Wim Ceelen
C3
Conference
2009
MDM2 amplification in colorectal carcinomas
Stéphanie Laurent
Piet Pattyn
Marc Peeters
Patrick Pauwels
C3
Conference
2009
Major hepatectomies increases risk of morbidity and mortality in simultaneous resection of synchronous liver metastases and colorectal cancer
BERT VAN DEN BOSSCHE
KIM BOTERBERGH
Stéphanie Laurent
ISABEL DERO
Frederik Berrevoet
Marc Peeters
Bernard de Hemptinne
Roberto Troisi
C3
Conference
2009
Mdm2 in colon carcinoma: an immunohistochemical and fluorescence in situ hybridization study
Monirath Hav
Louis Libbrecht
Piet Pattyn
Marc Peeters
Marleen Praet
Patrick Pauwels
C3
Conference
2009
PET evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
Nancy Van Damme
Christophe Van De Wiele
Wim Ceelen
Stéphanie Laurent
ISABEL DERO
Karen Geboes
Bieke Lambert
Peter Smeets
Marc Peeters
C3
Conference
2009
Quality assurance and recommendations for quality assessment of screening colonoscopy in Belgium.
E Macken
T Moreels
P Pelckmans
Marc Peeters
D Baert
H Reynaert
Danny De Looze
J Vannoote
M Hiele
JL Coenegrachts
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors: the end of a story?
T Delaunoit
M Van den Eynde
I Borbath
P Demetter
G Demolin
Piet Pattyn
S Pauwels
Marc Peeters
G Roeyen
E Van Cutsem
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
E Van Cutsem
F Rivera
S Berry
A Kretzschmar
M Michael
M DiBartolomeo
MA Mazier
JL Canon
V Georgoulias
Marc Peeters
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2009
Similarities between total mesorectal excision for rectal cancer and total mesoduodenal excision during pancreaticoduodenectomy for adenocarcinoma of the pancreatic head: the need for effective locoregional lymfadenectomy
Frederik Berrevoet
Francis Goudsmedt
Louis Libbrecht
Xavier Rogiers
Roberto Troisi
Marc Peeters
Bernard de Hemptinne
C3
Conference
2009
Surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis from colorectal cancer
Wim Ceelen
Yves Van Nieuwenhove
Dirk Van de Putte
Marc Peeters
Piet Pattyn
C3
Conference
2009
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours.
C Verslype
S Carton
I Borbath
T Delaunoit
P Demetter
G Demolin
A Hendlisz
Piet Pattyn
S Pauwels
Marc Peeters
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
The potential role of targeted therapies in the management of neuroendocrine tumours
G Verset
I Borbath
T Delaunoit
P Demetter
G Demolin
A Hendlisz
Piet Pattyn
S Pauwels
Marc Peeters
G Roeyen
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
The role of surgery and transplantation in neuroendocrine tumours
G Roeyen
T Chapelle
I Borbath
T Delaunoit
P Demetter
G Demolin
A Hendlisz
Piet Pattyn
S Pauwels
Marc Peeters
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2009
Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma
D Sebag-Montefiore
H Rutten
E Rullier
Marc Peeters
G Brown
E Van Cutsem
S Ricci
C Van de Velde
P Quirke
R Glynne-Jones
C3
Conference
2009
Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors
Christophe Van De Wiele
Luc Defreyne
Marc Peeters
Bieke Lambert
A1
Journal Article
in
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009
2008
A Phase IB/IIA, multicentre, randomised, double-blind placebo controlled study to evaluate the safety and pharmacokinetics of Z-360 in subjects with unresectable advanced pancreatic cancer in combination with gemcitabine
T MEYER
M CAPLIN
D PALMER
J VALLE
M LARVIN
J WATERS
F COXON
I BORBATH
Marc Peeters
E NAGANO
et al.
C1
Conference
2008
A Phase IB/IIA, multicentre, randomised, double-blind placebo controlled study to evaluate the safety and pharmacokinetics of Z-360 in subjects with unresectable advanced pancreatic cancer in combination with gemcitabine
J VAN LAETHEM
E VAN CUTSEM
P HAMMEL
D AZRIA
F MORNEX
G VAN TIENHOVEN
Marc Peeters
E NAGANO
H KATO
C1
Conference
2008
Adjuvant chemoradiation after curative resection for pancreatic cancer is feasible: results of a randomised EORTC/FFCD/GERCOR study
J VAN LAETHEM
E VAN CUTSEM
P HAMMEL
D AZRIA
F MORNEX
G VAN TIENHOVEN
Marc Peeters
P VERGAUWEN
V BUDACH
L COLLETTE
et al.
C1
Conference
2008
Adjuvant chemoradiation alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR study (40013/22012/0304)
J VAN LAETHEM
E VAN CUTSEM
P HAMMEL
F MORNEX
D AZRIA
G VAN TIENHOVEN
Marc Peeters
Marleen Praet
V BUDACH
K HAUSTERMANS
C1
Conference
2008
Adjuvante behandeling coloncarcinoom
Marc Peeters
A4
Journal Article
in
Oncology News International
2008
Advances in the management of gastrointestinal stromal tumours
Sybile Van Lierde
Marc Peeters
Nancy Van Damme
Karen Geboes
Stéphanie Laurent
ISABEL DERO
Patrick Pauwels
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2008
Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition.
B Jacobs
R Van Oirbeek
B Biesmans
S Fieuws
W De Roock
J De Schutter
Y Humblet
Marc Peeters
E Van Cutsem
S Tejpar
C3
Conference
2008
An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
E VAN CUTSEM
S SIENA
Y HUMBLET
JL CANON
J MAUREL
E BAJETTA
B NEYNS
D KOTASEK
A SANTORO
W SCHEITHAUER
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2008
Association of KRAS mutational status and efficacy of panitumumab monotherapy for the treatment (tx) of metastatic colorectal cancer (mCRC): results of pooled data from 4 clinical studies.
R Amado
M Wolf
D Freeman
M Reiner
E Van Cutsem
Marc Peeters
S Siena
JR Hecht
J Berlin
D Chang
C3
Conference
2008
COST-EFFECTIVENESS OF PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) COMPARED WITH BSC ALONE IN CHEMOREFRACTORY METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS) WITH WILD-TYPE (WT) KRAS TUMOR STATUS IN THE NETHERLANDS
C Graham
R Borker
M Oppe
C Uyl-de Groot
B Barber
A Brogan
R Amado
Marc Peeters
G Devercelli
C3
Conference
2008
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab: A fluorescent in situ hybridization study
N PERSONENI
S FIEUWS
H PIESSEVAUX
G DE HERTOGH
J DE SCHUTTER
B BIESMANS
W DE ROOCK
A CAPOEN
M DEBIEC-RYCHTER
JL VAN LAETHEM
et al.
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2008
Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treted with cetuximab: a fluorescent in situ hybridization study
N PERSONENI
S FIEUWS
H PIESSEVAUX
G DE HERTOGH
J DE SCHUTTER
B BIESMANS
W DE ROOCK
A CAPOEN
M DEBIEC-RYCHTER
J VAN LAETHEM
et al.
C1
Conference
2008
Correlation of high amphiregulin and epiregulin expression in KRAS wild type colorectal primaries with response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease.
S TEJPAR
W DE ROOCK
B BIESMANS
J DE SCHUTTER
H PIESSEVAUX
Y HUMBLET
Marc Peeters
I CELIK
E VAN CUTSEM
C1
Conference
2008
DUSP4 expression level in colorectal primaries predicts overall survival benefit in Kras wild-type and Kras mutant colorectal cancer after treatment with cetuximab for metastatic disease.
W De Roock
M Janssens
B Biesmans
B Jacobs
J De Schutter
Y Humblet
Marc Peeters
E Van Cutsem
P Marynen
S Tejpar
C3
Conference
2008
Differential gene expression between metastatic colorectal tumours in liver and peritoneum.
Nancy Van Damme
Wim Ceelen
Piet Pattyn
Bernard de Hemptinne
P VAN HUMMELEN
Marc Peeters
C1
Conference
2008
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with 3 different contrast agents for therapy monitoring in a tumour bearing mouse model.
Veerle Casneuf
Louke Delrue
Nancy Van Damme
Pieter Demetter
Tom Boterberg
P ROBERT
Philippe Duyck
Marc Peeters
C1
Conference
2008
EFFECTS OF THE LOW MOLECULAR WEIGHT HEPARIN NADROPARIN ON TUMOR ASSOCIATED ANGIOGENESIS
Isabelle Debergh
Marc Peeters
Wim Ceelen
C3
Conference
2008
Effects of the low molecular weight heparin nadroparin on tumor associated angiogenesis
Isabelle Debergh
Nancy Van Damme
Piet Pattyn
Marc Peeters
Wim Ceelen
C3
Conference
2008
Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis
Isabelle Debergh
Nancy Van Damme
Marc Peeters
Piet Pattyn
Wim Ceelen
C1
Conference
2008
Evaluation of EGFR and K-RAS gene status in squamous cell carcinoma of the anal canal.
Nancy Van Damme
Nadine Van Roy
Franki Speleman
A BOLS
J VAN DORPE
Patrick Pauwels
Marc Peeters
C3
Conference
2008
Expression of SGLT1 and Bcl-2 in pancreatic cancer and their metastases related to survival
Veerle Casneuf
Nancy Van Damme
Patrick Pauwels
Philippe Fonteyne
Bernard de Hemptinne
Christophe Van De Wiele
Marc Peeters
C3
Conference
2008
Expression of SGLT1 and Bcl-2 in panreatic cancer and their metastases related to survival.
Veerle Casneuf
Nancy Van Damme
Philippe Fonteyne
Patrick Pauwels
Bernard de Hemptinne
Christophe Van De Wiele
Marc Peeters
C3
Conference
2008
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
Veerle Casneuf
Philippe Fonteyne
Nancy Van Damme
Pieter Demetter
Patrick Pauwels
Bernard de Hemptinne
Martine De Vos
Christophe Van De Wiele
Marc Peeters
A1
Journal Article
in
CANCER INVESTIGATION
2008
Expression of hexokinase II in pancreatic cancer predicts survival
Veerle Casneuf
Philippe Fonteyne
Nancy Van Damme
Patrick Pauwels
Bernard de Hemptinne
Christophe Van De Wiele
Marc Peeters
C1
Conference
2008
Functionele beeldvorming van respons op anti-angiogene therapie
Peter Smeets
Wim Ceelen
Nancy Van Damme
Veerle Casneuf
Christophe Van De Wiele
Marc Peeters
A4
Journal Article
in
Up to date
2008
Gene expression differentiates liver metastases from isolated peritoneal metastases in colorectal cancer
Wim Ceelen
Nancy Van Damme
P Van Hummelen
Piet Pattyn
Bernard de Hemptinne
Marc Peeters
C3
Conference
2008
Health-related quality of life (HRQOL) and colorectal cancer (CRC) symptoms in metastatic CRC: panitumumab plus best supportive care (BSC) vs. BSC alone by kras tumor status.
D Odom
G Devercelli
L Bennett
Marc Peeters
M Wolf
R Amado
C3
Conference
2008
Influence of neoadjuvant chemoradiation on surgical outcome following Ivor Lewis esophagectomy for cancer of the distal esophagus and gastric cardia
WIM CEELEN
Dirk Van de Putte
Tom Boterberg
Marc Peeters
J GILLARDIN
Pieter-Jan Elshout
Julie Bontinck
Oswald Varin
Piet Pattyn
C1
Conference
2008
Investigation of the EGFR and K-RAS gene status in squamous cell carcinoma of the anal canal
Nancy Van Damme
Nadine Van Roy
Pieter Demetter
Franki Speleman
A Bols
Jo Van Dorpe
N Nagy
J Van Laethem
Patrick Pauwels
Marc Peeters
C3
Conference
2008
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
W DE ROOCK
H PIESSEVAUX
J DE SCHUTTER
M JANSSENS
G DE HERTOGH
N PERSONENI
B BIESMANS
JL VAN LAETHEM
Marc Peeters
Y HUMBLET
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2008
Laparoscopic versus open liver resections for malingancy. A Case control study.
F PEZZOLI
MAURICIO SAINZ-BARRIGA
A SAGNOTTA
LAURA DE CALUWE
F FAVI
H MAES
FREDERICK D'HONDT
D VANDERFRAENEN
B CASIER
ISABEL DERO
et al.
C1
Conference
2008
Management of lesions of the ampulla of vater: is local excision justified?
Frederik Berrevoet
Roberto Troisi
Danny De Looze
Xavier Rogiers
Marc Peeters
Martine De Vos
Bernard de Hemptinne
C1
Conference
2008
Microsatellite instability in Belgian sporadic colon carcinomas has no independent prognostic value in a Belgian study population
Vanessa Deschoolmeester
Nancy Van Damme
Marc Baay
K Claes
Eric Van Marck
J F Baert
Wim Wuyts
M Cabooter
J Weyler
Peter Vermeulen
et al.
C3
Conference
2008
Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population
V DESCHOOLMEESTER
Nancy Van Damme
M BAAY
Kathleen Claes
E VAN MARCK
F BAERT
W WUYTS
M CABOOTER
J WEYLER
P VERMEULEN
et al.
A1
Journal Article
in
European Journal of Cancer
2008
Molecular imaging of tumor associated angiogenesis using P1227, a noval MRI contrast agent targeting Alfa V Beta 3 integrin
Isabelle Debergh
Nancy Van Damme
Peter Smeets
Piet Pattyn
Marc Peeters
Wim Ceelen
C3
Conference
2008
Molecular imaging of tumor associated angiogenesis uzing P1127, a novel MRI contrast agent targeting alfa V beta 3 integrin
Isabelle Debergh
Nancy Van Damme
Peter Smeets
Marc Peeters
Piet Pattyn
Wim Ceelen
C3
Conference
2008
Outcome of colorectal versus non-colorectal liver metastases. A case-control study.
F PEZZOLI
MAURICIO SAINZ-BARRIGA
Frederik Berrevoet
F FAVI
A SAGNOTTA
LAURA DE CALUWE
H MAES
ANNA ROSSETTO
FREDERICK D'HONDT
D VANDERFRAENEN
et al.
C1
Conference
2008
Panitumumab (pmab) efficacy and patient-reported outcomes in metastatic colorectal cancer patients with wild-type KRAS tumor status.
R AMADO
M WOLF
D FREEMAN
Marc Peeters
E VAN CUSTEM
S SIENA
S SUGGS
G DEVERCELLI
M WOOLLEY
D CHANG
C1
Conference
2008
Phase III study (20050181) of panitumumab (pmab) with FOLFIRI versus FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC) pooled safety results
Marc Peeters
G WILSON
M DUCREUX
A VERVANTES
T ANDRé
Y HOTKO
F LORDICK
S COLLINS
M SHING
T PRICE
C3
Conference
2008
Phase III study (20050181) of panitumumab with FOLFIRI compared to FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer: preliminary safety results.
Marc Peeters
G WILSON
Y HOTKO
M DUCREUX
A CERVANTES
T ANDRé
F LORDICK
S COLLINS
M SHING
T PRICE
C1
Conference
2008
Prognostic significance of pathological response to neoadjuvant chemoradiation in carcinoma of the esophagus and gastric cardia
WIM CEELEN
Dirk Van de Putte
Tom Boterberg
Marc Peeters
MARC GILLARDIN JEAN
Pieter-Jan Elshout
Julie Bontinck
Oswald Varin
Piet Pattyn
C1
Conference
2008
Relationship of efficacy with KRAS status (wild type versus mutant) in patients with irinotecan-refactory metastatic colorectal cancer (mCRC), treated wth irinotecan (q2w) and escalating dose of cetuximab (q1w): the EVEREST experience (preliminary data)
S TEJPAR
Marc Peeters
Y HUMBLET
J VERMORKEN
G DE HERTOGH
W DE ROOCK
J NIPPGEN
A VON HEYDEBROECK
C STROH
E VAN CUTSEM
C1
Conference
2008
Review article: panitumumab - a fully human anti-EGFR monoclonal antibody for treatment of metastatic colorectal cancer
Marc Peeters
J BALFOUR
D ARNOLD
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2008
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin in patients with peritoneal carcinomatosis
Wim Ceelen
Marc Peeters
Christophe Breusegem
PHILIPPE HOUTMEYERS
Filip De Somer
Piet Pattyn
C3
Conference
2008
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis
Wim Ceelen
Marc Peeters
PHILIPPE HOUTMEYERS
Christophe BREUSEGEM
Filip De Somer
Piet Pattyn
A1
Journal Article
in
ANNALS OF SURGICAL ONCOLOGY
2008
The EVEREST study: relationship between efficacy and K-RAS mutation status in patients with irinotecan-refactory MCRC treated with irinotecan and standard or escalating doses of cetuximab
S TEJPAR
Marc Peeters
Y HUMBLET
H GELDERBLOM
J VERMORKEN
G DE HERTOGH
W DE ROOCK
J NIPPGEN
A VON HEYDERBRECK
C STROH
et al.
C1
Conference
2008
The role of oral fluoropyrimidines in the treatment of advanced gastric cancer
An Pieters
Stéphanie Laurent
ISABEL DERO
Nancy Van Damme
Marc Peeters
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2008
Trends in morbidity and mortality in major liver resection. A single institutional experience.
F PEZZOLI
MAURICIO SAINZ-BARRIGA
F FAVI
A SAGNOTTA
LAURA DE CALUWE
H MAES
A ROSSETTO
FREDERICK D'HONDT
D VANDERFRAENEN
B CASIER
et al.
C1
Conference
2008
Two-step hepatectomy based on intraoperative portal vein embolization and resection of colorectal metastases in the contralateral lobe does not enhance tumoral recurrence and allow complete resection of multiple bilateral metastases while chemotherapy
Roberto Troisi
MAURICIO SAINZ-BARRIGA
Frederik Berrevoet
A SAGNOTTA
F PEZZOLI
ANNA ROSSETTO
L DE CALUWE
F FAVI
HILDE MAES
F D'HONDT
et al.
C1
Conference
2008
Unusual serum electrophoresis pattern in a woman with pancreatic carcinoma
Joris Delanghe
Marc De Buyzere
Veerle Casneuf
Marc Peeters
Editorial material
2008
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
RG AMADO
M WOLF
Marc Peeters
E VAN CUTSEM
S SIENA
DJ FREEMAN
T JUAN
R SIKORSKI
S SUGGS
R RADINSKY
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2008
2007
A phase III randomized controlled trial of panitumumab in patients with metastatic colorectal cancer: subset analyses in elderly patients and in patients with poor performance status.
E VAN CUTSEM
Marc Peeters
S SIENA
Y HUMBLET
A HENDLISZ
B NEYNS
J CANON
J VAN LAETHEM
M WOLF
R AMADO
C1
Conference
2007
Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomised EORTC/FFCD/GERCOR phase I/II study (40013/22012/0304)
J VAN LAETHEM
E VAN CUSTEM
P HAMMEL
F MORNEX
D ARZIA
G VAN TIENHOVEN
Marc Peeters
Marleen Praet
V BUDACH
K HAUSTERMANS
C1
Conference
2007
Assessment of therapy response by DCE-MRI with a macromolecular gadolinium contrast agent.
Peter Smeets
Wim Ceelen
Tom Boterberg
Nancy Van Damme
Marc Peeters
Koenraad Verstraete
C1
Conference
2007
Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
S SIENA
Marc Peeters
E VAN CUTSEM
Y HUMBLET
P CONTE
E BAJETTA
D COMANDINI
G BODOKY
G VAN HAZEL
T SALEK
et al.
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2007
Association of skin toxicity (ST) severity with clinical outcomes and health-related quality of life (HRQoL) with panitumumab (Pmab)
Y HUMBLET
Marc Peeters
S SIENA
A HENDLISZ
B NEYNS
A SOBRERO
M WOLF
M WOOLLEY
R AMADO
E VAN CUTSEM
C1
Conference
2007
Cetuximab dose-escalation in mCRC patients with no or slight skin reactions on standard treatment (EVEREST).
E VAN CUTSEM
Marc Peeters
H GERLDERBLOM
J VERMORKEN
F VIRET
B GLIMELIUS
F CIARDIELLO
E GALLERINI
D WEBER
Y HUMBLET
C1
Conference
2007
Cetuximab dose-escalation study in patients with metastatic colorectal cancer with no or slight skin reactions on cetuximab dose treatment (EVEREST): pharmacokinetic and efficacy data of a randomized study.
E VAN CUTSEM
Y HUMBLET
H GELDERBLOM
J VERMORKEN
F VIRET
B GLIMELIUS
F CIADIELLO
E GALLERANI
N AMELLAL
Marc Peeters
C1
Conference
2007
Converging expression profiles from esophageal and colorectal cancer tissues: a comparative analysis using expression microarray.
Nancy Van Damme
J ALLEMEERSCH
Philippe Fonteyne
Wim Ceelen
Tom Boterberg
Marc Peeters
P VAN HUMMELEN
C1
Conference
2007
Converging expression profiles from oesophageal and colorectal cancer tissues: a comparative analysis using expression microarray.
Nancy Van Damme
J ALLEMEERSCH
Philippe Fonteyne
Wim Ceelen
Tom Boterberg
Marc Peeters
P VAN HUMMELEN
C1
Conference
2007
Cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (HIPEC): toxicity, survival and prognostic variables in 130 patients with peritoneal carcinomatosis.
WIM CEELEN
Marc Peeters
PHILIPPE HOUTMEYERS
Christophe Breusegem
Filip De Somer
Piet Pattyn
C1
Conference
2007
Diagnostic superiority of PET/CT over PET in patients with pancreatic disease.
Veerle Casneuf
Louke Delrue
A KELLES
Philippe Duyck
Marc Peeters
C1
Conference
2007
Dose-finding study using oxaliplatin in combination with fixed dose gemcitabin and radiotherapy in patients with locally advanced pancreatic or biliary tract cancer.
E MONSAERT
Tom Boterberg
Marc Peeters
I BORBATH
A DEMOLS
M POLUS
P SCALLIET
TINE DERRE
J VAN LAETHEM
C1
Conference
2007
EUS-guided FNA of pancreatic lesions: a single centre experience.
Ercan Cesmeli
Jacques Van Huysse
Veerle Casneuf
Claude Cuvelier
Marc Peeters
Martine De Vos
C1
Conference
2007
Efficacy and safety of panitumumab across five clinical studies in patients with metatastic colorectal cancer.
Marc Peeters
E VAN CUTSEM
J HECHT
J BERLIN
R RUIZ
L NAVALE
R AMADO
N MEROPOL
C1
Conference
2007
Efficacy of pancreaticoduodenectomy with en bloc portal vein resection for pancreatic head carcinoma with suspected portal vein involvement
Frederik Berrevoet
Roberto Troisi
Veerle Casneuf
Marc Peeters
Bernard de Hemptinne
C1
Conference
2007
Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study
G VERSET
C VERSLYPE
H REYNAERT
I BORBATH
P LANGLET
A VANDEBROEK
Marc Peeters
G HOUBIERS
S FRANCQUE
M ARVANITAKIS
et al.
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2007
GLEM/LOK report on staging procedures in digestive tumours: results, comments and recommendations.
Marc Peeters
C DE GALOCSY
E VANDERSTRAETEN
J DEBONGNIE
R FIASSE
André Elewaut
C1
Conference
2007
Is combined F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography superior to Positron Emission Tomography or Computed Tomography alone for diagnosis, staging and restaging of pancreatic lesions ?
Veerle Casneuf
Louke Delrue
A KELLES
Nancy Van Damme
J VAN HUYSSE
Frederik Berrevoet
Martine De Vos
Philippe Duyck
Marc Peeters
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2007
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
Wim Ceelen
Tom Boterberg
Piet Pattyn
Marc Van Eijkeren
Jean-Pierre Gillardin
Pieter Demetter
Peter Smeets
Nancy Van Damme
ELS MONSAERT
Marc Peeters
A1
Journal Article
in
ANNALS OF SURGICAL ONCOLOGY
2007
Non-invasive confirmation of recurrent pancreatic cancer.
Veerle Casneuf
Louke Delrue
A KELLES
Philippe Duyck
Marc Peeters
C1
Conference
2007
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
E VAN CUTSEM
Marc Peeters
S SIENA
Y HUMBLET
A HENDLISZ
B NEYNS
JL CANON
JL VAN LAETHEM
J MAUREL
G RICHARDSON
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2007
Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion: formulation and stability
Wim Bouquet-Geerardyn
Wim Ceelen
Bernd Fritzinger
Piet Pattyn
Marc Peeters
Jean Paul Remon
Chris Vervaet
A1
Journal Article
in
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
2007
Patient-reported outcome (PRO)-assessed clinical benefit with panitumumab (Pmab) in metastatic colorectal cancer (mCRC) patients (pts)
A HENDLISZ
E VAN CUTSEM
Marc Peeters
Y HUMBLET
B NEYNS
A SOBRERO
G DEVERCELLI
M WOLF
R AMADO
S SIENA
C1
Conference
2007
Phase I/II study of cetuximab dose-escalation in patients with metastatic colorectal cancer (mCRC) with no or slight skin reactions on cetuximab standard dose treatment (EVEREST): pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data
S TEJPAR
Marc Peeters
Y HUMBLET
H GELDERBLOM
J VERMORKEN
F VIRET
B GLIMELIUS
F CIARDIELLO
O KISKER
E VAN CUTSEM
C1
Conference
2007
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
JP MACHIELS
C SEMPOUX
P SCALLIET
JC COCHE
Y HUMBLET
E VAN CUTSEM
J KERGER
JL CANON
Marc Peeters
S AYDIN
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2007
Predictive value of skin toxicity severity for response to panitumumab in patients with metastatic colorectal cancer (mCRC): a pooled analysis of five clinical trials
J BERLIN
E VAN CUTSEM
Marc Peeters
J HECHT
R RUIZ
M WOLF
R AMADO
N MEROPOL
C1
Conference
2007
Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
Wim Ceelen
Tom Boterberg
Peter Smeets
Nancy Van Damme
Pieter Demetter
O Zwaenepoel
Louis Cesteleyn
PHILIPPE HOUTMEYERS
Marc Peeters
Piet Pattyn
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2007
Safety of panitumumab, a fully huma monoclonal antibody against the epidermal growth factor receptor (EGFr), in patients with metastatic colorectal cancer (mCRC) across clinical trial
Marc Peeters
E VAN CUTSEM
J BERLIN
J HECHT
R RUIZ
L NAVALE
R AMADO
N MEROPOL
C1
Conference
2007
Squamous cell carcinoma of the anus: a possible target for EGFR inhibition?
Marc Peeters
Jacques Van Huysse
Nancy Van Damme
Stéphanie Laurent
ISABEL DERO
Tom Boterberg
Piet Pattyn
Patrick Pauwels
C1
Conference
2007
Vandetanib with Folfiri in patients with advanced colorectal adenocarcinoma: an open-label, multicenter phase I study
M SAUNDERS
E VAN CUTSEM
R WILSON
Marc Peeters
A SMITH
A GODWOOD
S OLIVER
C1
Conference
2007
2006
Adjuvante behandeling bij coloncarcinoom: is het 5-fluorouraciltijdperk voorbij?
KOEN VAN DYCKE
E MONSAERT
Piet Pattyn
WIM CEELEN
Tom Boterberg
Marc Peeters
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2006
Are von Willebrand factor and Ki-67 outcome predictors for esophageal cancer?
Nancy Van Damme
Pieter Demetter
I Delmotte
Wim Ceelen
Piet Pattyn
E Monsaert
Tom Boterberg
Marc Peeters
C3
Conference
2006
Capecitabine, Oxaliplatin, radiotherapy and excision (CORE) in patients with MIR-defined locally advanced rectal adenocarcinoma: results of an international multicenter phase II study
H Rutten
R Sebag-Montefiore
R Glynne-Jones
E Rullier
Marc Peeters
G Brown
E Van Cutsem
S Ricci
C Van de Velde
P Quirke
C3
Conference
2006
De behandeling van het colorectaal carcinoom is in volle expansie: systemische chemotherapie voor het gemetastaseerd colorectaal carcinoom
M PAELINCK
Marc Peeters
E MONSAERT
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2006
Does (PET)-P-18/CT influences therapeutic strategy in pancreatic lesions?
A KELLES
Veerle Casneuf
Louke Delrue
Philippe Duyck
Marc Peeters
C3
Conference
2006
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
A DEMOLS
Marc Peeters
M POLUS
R MARECHAL
F GAY
ELS MONSAERT
A HENDLISZ
JL VAN LAETHEM
A1
Journal Article
in
BRITISH JOURNAL OF CANCER
2006
Imatinib for the treatment of patients with unresectable or metastatic malignant KIT-positive gastrointestinal stromal tumours: an open-label Belgian trial
H PRENEN
H DUMEZ
C STEFAN
A HOEBEN
C WOUTERS
MA VAN LIERDE
R SCIOT
AT VAN OOSTEROM
Marc Peeters
M POLUS
et al.
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2006
Ki-67 and von Willebrand factor: outcome predictors for oesophageal cancer
Nancy Van Damme
Pieter Demetter
I DELMOTTE
Wim Ceelen
Piet Pattyn
E MONSAERT
Tom Boterberg
Marc Peeters
C1
Conference
2006
Neoadjuvant chemoradiation versus hyperfractionated accelerated radio-therapy (HART) in respectable dital rectal cancer
Wim Ceelen
O ZWAENEPOEL
J GILLARDIN
Tom Boterberg
Nancy Van Damme
Veerle Casneuf
Piet Pattyn
Marc Peeters
C1
Conference
2006
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
Wim Ceelen
O ZWAENEPOEL
J GILLARDIN
Tom Boterberg
Nancy Van Damme
Piet Pattyn
Marc Peeters
C3
Conference
2006
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
Wim Ceelen
O Zwaenepoel
Jean-Pierre Gillardin
Tom Boterberg
Nancy Van Damme
Piet Pattyn
Marc Peeters
C3
Conference
2006
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
Wim Ceelen
Peter Smeets
Walter Backes
Nancy Van Damme
Tom Boterberg
Pieter Demetter
ISABEL BOUCKENOOGHE
MARIEKE DE VISSCHERE
Marc Peeters
Piet Pattyn
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2006
Pre-operative combined modality therapy in the management of locally advanced rectal cancer
Wim Ceelen
Piet Pattyn
Tom Boterberg
Marc Peeters
A1
Journal Article
in
EJSO
2006
Purulente pericarditis met harttamponade: eerste manifestie van een slokdarmcarcinoom
LEEN DE BACKER
NATACHA VERBEKE
Marc Peeters
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2006
Use of PET/CT in pancreatic lesions
Veerle Casneuf
A KELLES
Louke Delrue
Nancy Van Damme
Frederik Berrevoet
Claude Cuvelier
Philippe Duyck
Bernard de Hemptinne
Marc Peeters
C3
Conference
2006
2005
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
H OETTLE
D RICHARDS
RK RAMANATHAN
JL VAN LAETHEM
Marc Peeters
M FUCHS
A ZIMMERMANN
W JOHN
D VON HOFF
M ARNING
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2005
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian Phase II study
A DEMOLS
Marc Peeters
M POLUS
P HONORE
Tom Boterberg
F GAY
MT CLOSON
P VAN HOUTTE
J CLOSSET
JL VAN LAETHEM
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2005
An international phase II study of Capecitabine, Oxaliplatin, Radiotherapy and Excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma. Interim results.
D SEBAG-MONTEFIORE
G BROWN
H RUTTEN
E RULLIER
Marc Peeters
R GLYNNE-JONES
E VAN CUTSEM
S RICCI
C VAN DE VELDE
P QUIRKE
C1
Conference
2005
An open-label, phase I study of cetuximab to assess the safety, efficacy and pharmacokinetics (PK) of different cetuximab regimens in patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC)
Y HUMBLET
Marc Peeters
H BLEIBERG
R STUPP
C SESSA
J ROTH
J NIPPGEN
A NOLTING
P STUART
G GIACCONE
C1
Conference
2005
Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)
Marc Peeters
J RAOUL
J VAN LAETHEM
P ROUGIER
C BREZAULT
F HUSSEINI
L CALS
A ZUBEL
J VEDOVATO
C1
Conference
2005
Een verhaal van 16 jaar gastro-intestinaal bloedverlies
M WITHOFS
E MONSAERT
Danny De Looze
P NACHTEGAELE
Marc Peeters
Martine De Vos
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2005
Effect of rh EPO on tissue oxygen and flow mapping: experimental study in a rat colorectal cancer model
Wim Ceelen
Nancy Van Damme
Tom Boterberg
Peter Smeets
Pieter Demetter
Marc Peeters
C1
Conference
2005
Het ene lymfoom is het andere niet
M PAELINCK
Marc Peeters
Danny De Looze
P MELKEBEKE
Marleen Praet
Martine De Vos
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2005
In vivo mapping of the effects of radiotherapy on neovascular permeability using dynamic contrast enhanced MRI
Pieter Pletinckx
Peter Smeets
Nancy Van Damme
Tom Boterberg
Pieter Demetter
Marc Peeters
Wim Ceelen
C3
Conference
2005
In vivo mapping of the effects of radiotherapy on neovascular permeability using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI)
Wim Ceelen
Peter Smeets
Nancy Van Damme
Tom Boterberg
Pieter Demetter
Mohamed El-Malt
Piet Pattyn
Marc Peeters
C3
Conference
2005
Influence of PET/CT on therapeutic strategy in pancreatic lesions
Veerle Casneuf
Louke Delrue
M KELLES
Philippe Duyck
Marc Peeters
C1
Conference
2005
Is chirurgie van de primaire tumor een noodzaak bij een gemetastaseerd colorectaal carcinoom?
E VANDERSTRAETEN
P BURVENICH
D BAERT
Marc Peeters
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2005
Limited influences of chemotherapy on healthy and metastatic liver parenchyma
Nancy Van Damme
Pieter Demetter
WOUTER DE BOCK
Marianne Rottiers
Marleen Praet
Bernard de Hemptinne
Marc Peeters
A1
Journal Article
in
WORLD JOURNAL OF GASTROENTEROLOGY
2005
Survial data of 87 adenocarcinomas of the pancreas
Veerle Casneuf
Pieter Demetter
Louke Delrue
Bernard de Hemptinne
Marc Peeters
C1
Conference
2005
Survival data of 87 adenocarcinomas of the pancreas
V CASNEUF
Pieter Demetter
L DELRUE
Bernard de Hemptinne
Marc Peeters
C3
Conference
2005
Taxol versus paclitaxel beta-cyclodextrin complexes for hyperthermic peritoneal perfusion: an in vivo study
Wim Bouquet-Geerardyn
Tom Boterberg
WIM CEELEN
Chris Vervaet
Marcus Mareel
Marc Peeters
C1
Conference
2005
Voedingstoestand bij kanker
Veerle Casneuf
Nancy Van Damme
E Monsaert
Marc Peeters
Newsarticle
2005
2004
An randomized phase III study comparing gemcitabine + pemetrexed versus gemcitabine in patients with locally advanced and metastatic pancreatic cancer
D RICHARDS
H KINDLER
H OETTLE
R RAMANATHAN
J VAN LAETHEM
Marc Peeters
M FUCHS
W JOHN
M ARNING
D VON HOFF
C1
Conference
2004
CPT-11 and mitomycin-C in heavily pre-treated patients with metastatic colorectal cancer: a belgian multicentre phase II study
M POLUS
Marc Peeters
F BAERT
P VERGAUWE
H KAKANTARI
K HENDRICKX
J COLLIGNON
P VAN MAELE
L VANDEPUTTE
J VAN LAETHEM
C1
Conference
2004
Cetuximab + FOLFIRI as first-line treatment for metastatic colorectal CA
P ROUGIER
J RAOUL
J VAN LAETHEM
Marc Peeters
F HUSSEINI
C BREZAULT
L CALS
J VEDOVATO
M MUESER
C1
Conference
2004
Clinical implementation of intensity modulated arc therapy (IMAT) for rectal cancer.
Wim Duthoy
Werner De Gersem
Tom Boterberg
Peter Smeets
Marc Peeters
Wilfried De Neve
C3
Conference
2004
Clinical implementation of intesity modulated arc therapy (IMAT) for rectal cancer
WIM DUTHOY
Werner De Gersem
Tom Boterberg
Peter Smeets
Marc Peeters
Wilfried De Neve
C1
Conference
2004
Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with Tc-99m-HMPAO white blood cell scintigraphy
RJ BENNINK
Marc Peeters
P RUTGEERTS
L MORTELMANS
A1
Journal Article
in
JOURNAL OF NUCLEAR MEDICINE
2004
Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study
J VAN LAETHEM
M POLUS
R MARECHAL
A DEMOLS
F GAY
M MARIJKEN
A HENDLISZ
Marc Peeters
C1
Conference
2004
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
Nancy Van Damme
Pieter Demetter
WOUTER DE BOCK
Bernard de Hemptinne
Marleen Praet
Marc Peeters
C1
Conference
2004
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
Nancy Van Damme
Pieter Demetter
WOUTER DE BOCK
Bernard de Hemptinne
Marleen Praet
Marc Peeters
C1
Conference
2004
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
Nancy Van Damme
Pieter Demetter
W DE BOCK
Bernard de Hemptinne
Marleen Praet
Marc Peeters
C3
Conference
2004
Metastatic follicular dendritic cell sarcoma of the stomach: A case report and review of the literature
Anja Geerts
E LAGAE
K DHAENE
Marc Peeters
Anouk Waeytens
Pieter Demetter
Claude Cuvelier
Luc Defreyne
Martine De Vos
Piet Pattyn
A1
Journal Article
in
ACTA GASTRO-ENTEROLOGICA BELGICA
2004
Phase II study of irinotecan + 5FU/FA for patients with previously treated advanced gastric cancer
Marc Peeters
J VAN LAETHEM
F BAERT
J CANON
J DE GRÈVE
H KALANTARI
P DHONT
E VAN CUTSEM
C1
Conference
2004
Prognostic value of FAS expression in pancreatic adenocarcinoma
Pieter Demetter
S CLAEYS
Marc Peeters
Bernard de Hemptinne
Claude Cuvelier
C1
Conference
2004
Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study
JL VAN LAETHEM
P VAN MAELE
C VERSLYPEC
M POLUS
A DEMOLS
G HOUBIERS
P CAENEPEEL
A LELEUX
RR VERMAUT
E VAN CUTSEM
et al.
A1
Journal Article
in
ONCOLOGY
2004
Routine microsatellite instability testing in sporadic colorectal tumours
Nancy Van Damme
Pieter Demetter
Kathleen Claes
Bruce Poppe
F BAERT
J ROELENS
Anne De Paepe
Claude Cuvelier
Marc Peeters
C3
Conference
2004
2003
18-fluorodeoxyglucose positron emission tomography in nonendocrine neoplastic disorders of the gastrointestinal tract
A ANNOVAZZI
Marc Peeters
A MAENHOUT
A SIGNORE
Rudi Dierckx
C VAN DE WIELE
A1
Journal Article
in
GASTROENTEROLOGY
2003
A retrospective analysis of the efficacy and toxicity of irinotecan and 5FU/FA in patients with advanced carcinoma of the stomach or oesophagogastric junction
ELS MONSAERT
Martine De Vos
Marc Peeters
C1
Conference
2003
Adjuvant gemcitabine (GEM) and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter belgian phase II study
A DEMOLS
Marc Peeters
M POLUS
Tom Boterberg
Uwe Hesse
F GAY
J VAN LAETHEM
C1
Conference
2003
Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy
Ilse Hoffman
Pieter Demetter
Marc Peeters
Martine De Vos
Herman Mielants
Eric Veys
Filip De Keyser
A1
Journal Article
in
ANNALS OF THE RHEUMATIC DISEASES
2003
Are carcinomas of the cardia oesophageal or gastric adenocarcinomas?
A DRIESSEN
D VAN RAEMDONCK
P DE LEYN
L FILEZ
Marc Peeters
V WINNEPENNINCKX
F PENNINCKX
T LERUT
N ECTORS
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2003
De rol van visvetzuren bij kanker cachexie
Marc Peeters
Séverine Morel
Nancy Van Damme
A4
Journal Article
in
TIJDSCHRIFT VOOR VOEDING EN DIETETIEK
2003
Follicular dendritic cell sarcoma of the stomach: case report and review of the literature
Pieter Demetter
Anja Geerts
E LAGAE
K DHAENE
Marc Peeters
Anouk Waeytens
Luc Defreyne
Martine De Vos
Piet Pattyn
Claude Cuvelier
C1
Conference
2003
Influences of chemotherapy on healthy and metastatic liver parenchyma is limited
Pieter Demetter
WOUTER DE BOCK
Nancy Van Damme
Martine De Vos
Bernard de Hemptinne
Luc Defreyne
M ROTTIERS
Marleen Praet
Marc Peeters
C1
Conference
2003
Pharmacodynamic studies of tumor biopsy specimens from patients with advanced gastric carcinoma undergoing treatment with genfinitib (ZD1839)
F ROJO
J TABERNERO
E VAN CUTSEM
A OHTSU
J ALBANELL
W KIOZUMI
Marc Peeters
S AVERBUCH
N GALLAGHER
J BASELGA
C1
Conference
2003
Phase II study of cetuximab combined with FOLFIRI (bi-weekly irinotecan plus infusional 5-FU and folinic acid (FA)) in patients with metastatic, Epiderman Growth Factor Receptor (EGFR)-expressing colorectal cancer
J RAOUL
J VAN LAETHEM
E MITRY
C BREZAULT
F HUSSEINI
L CALS
Marc Peeters
J VEDOVATO
M MUESER
P ROUGIER
C1
Conference
2003
Raltitrexed/gemcitabine in patients with advanced biliary tract adenocarcinoma: a phase II study
Marc Peeters
A DEMOLS
E VAN CUTSEM
P CAENEPEEL
A VERSLYPE
A TAGNON
P VAN MAELE
K DAEMS
R VERMAUT
J VAN LAETHEM
C1
Conference
2003
Therapie van het colorectaal carcinoom : kunnen biologische merkers het beleid beïnvloeden?
B Sierens
Marc Peeters
Bruce Poppe
Anne De Paepe
Pieter Demetter
Claude Cuvelier
Martine De Vos
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2003
Therapie van het colorectaal carcinoom: kunnen prognostische merkers ons beleid beïnvloeden?
B SIERENS
Marc Peeters
B POPPE
A DE PAEPE
Pieter Demetter
C CUVELIER
Martine De Vos
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2003
2002
Omgaan met darmkanker.
Marc Peeters
Tom Boterberg
W CEELEN
M VERBEKE
Book
2002
Radiolabelled thymidines and deoxyuridines for measuring cellular proliferation in tumours - an update.
C VAN DE WIELE
P DE BONDT
Marc Peeters
Hubert Vermeersch
Rudi Dierckx
Editorial material
2002
The value of serologic markers in indeterminate colitis : a prospective follow-up study
S Joossens
W Reinisch
S Vermeire
B Sendid
D Poulain
Marc Peeters
K Geboes
X Bossuyt
P Vandewalle
G Oberhuber
et al.
A1
Journal Article
in
GASTROENTEROLOGY
2002
Wanneer speelt erfelijkheid een rol
Anne De Paepe
Bruce Poppe
Bookchapter
in
Omgaan met darmkanker
2002
2001
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families
S Vermeire
Marc Peeters
R Vlietinck
S Joossens
E Den Hond
V Bulteel
X Bossuyt
B Geypens
P Rutgeer
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2001
Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.
S VERMEIRE
S JOOSSENS
Marc Peeters
F MONSUUR
G MARIEN
X BOSSUYT
P GROENEN
R VLIETINCK
P RUTGEERTS
A1
Journal Article
in
GASTROENTEROLOGY
2001
Diagnostic value of anti-Saccharomyces cerevisae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Marc Peeters
S JOOSSENS
S VERMEIRE
R VLIETINCK
X BOSSUYT
P RUTGEERTS
A1
Journal Article
in
AMERICAN JOURNAL OF GASTROENTEROLOGY
2001
Evidence for inflammatory dowel disease of a susceptibility locus on the x chromosome
S VERMEIRE
J SATSANGI
Marc Peeters
M PARKES
DP JEWELL
R VLIETINCK
P RUTGEERTS
A1
Journal Article
in
GASTROENTEROLOGY
2001
Inflammatory bowel disease in spouses and their offspring.
D LAHARIE
S DEBEUGNY
Marc Peeters
A VAN GOSSUM
C GOWER-ROUSSEAU
J BELAICHE
R FIASSE
JL DUPAS
E LEREBOURS
S PIOTTE
et al.
A1
Journal Article
in
GASTROENTEROLOGY
2001
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.
G D'HAENS
L LEMMENS
K GEBOES
L VANDEPUTTE
F VAN ACKER
L MORTELMANS
Marc Peeters
S VERMEIRE
F PENNINCKX
F NEVENS
et al.
A1
Journal Article
in
GASTROENTEROLOGY
2001
Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation.
D DOMBROWICZ
S NUTTEN
P DESREUMAUX
C NEUT
G TORPIER
Marc Peeters
JF COLOMBEL
M CAPRON
A1
Journal Article
in
JOURNAL OF EXPERIMENTAL MEDICINE
2001
Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis.
R BENNINK
Marc Peeters
G D'HAENS
P RUTGEERTS
L MORTELMANS
A1
Journal Article
in
CLINICAL NUCLEAR MEDICINE
2001
Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET)
P Flamen
OS Hoekstra
F Homans
E Van Cutsem
A Maes
S Stroobants
Marc Peeters
F Penninckx
L Filez
RP Bleichrodt
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2001
2000
Diagnostic approach to IBD
S VERMEIRE
Marc Peeters
P RUTGEERTS
A1
Journal Article
in
HEPATO-GASTROENTEROLOGY
2000
Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.
S VERMEIRE
Marc Peeters
R VLIETINCK
M PARKES
J SATSANGI
D JEWELL
P RUTGEERTS
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2000
Familial and sporadic inflammatory bowel disease: different entities?
Marc Peeters
A Cortot
S Vermeire
JF Colombel
A1
Journal Article
in
INFLAMMATORY BOWEL DISEASES
2000
Multifocal epithelioid angiosarcoma of the small intestine.
V DELVAUX
R SCIOT
B NEUVILLE
P MOERMAN
Marc Peeters
L FILEZ
D VAN BECKEVOORT
N ECTORS
K GEBOES
A1
Journal Article
in
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
2000
The effects of smoking and indomethacin on small intestinal permeability.
P SUENAERT
V BULTEEL
E DEN HOND
M HIELE
Marc Peeters
F MONSUUR
Y GHOOS
P RUTGEERTS
A1
Journal Article
in
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2000
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
P FLAMEN
A LERUT
E VAN CUSTEM
JP CAMBIER
A MAES
W DE WEVER
Marc Peeters
P DE LEYN
D VAN RAEMDONCK
L MORTELMANS
A1
Journal Article
in
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
2000
Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
E LOUIS
Marc Peeters
D FRANCHIMONT
L SEIDEL
F FONTAINE
G DEMOLIN
F CROES
P DUPONT
L DAVIN
S OMRI
et al.
A1
Journal Article
in
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2000
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
P FLAMEN
A LERUT
E VAN CUTSEM
W DE WEVER
Marc Peeters
S STROOBANTS
P DUPONT
G BORMANS
M HIELE
P DE LEYN
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2000
1999
Interpatient genetic variability of HIV-1 group O.
W JANSSENS
L HEYNDRICKX
G VAN DER AUWERA
J NKENGASONG
E BEIRNAERT
K VEREECKEN
S COPPENS
B WILLEMS
K FRANSEN
Marc Peeters
et al.
A1
Journal Article
in
AIDS
1999